首页> 外文期刊>Lipids in Health Disease >Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway
【24h】

Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway

机译:Syndecan-1通过独立于低密度脂蛋白受体相关蛋白(LRP)的非clathrin介导的途径介导apoE-VLDL的内在化

获取原文
           

摘要

Background Triacylglyerol-rich very low density lipoprotein (VLDL) particles are the primary carriers of fatty acids in the circulation and as such serve as a rich energy source for peripheral tissues. Receptor-mediated uptake of these particles is dependent upon prior association with apolipoprotein E (apoE-VLDL) and is brought about by cell surface heparan sulfate proteoglycans (HSPG) in some cell types and by the low density lipoprotein receptor-related protein (LRP) in others. Although LRP's role in apoE-VLDL uptake has been well studied, the identity of the HSPG family member that mediates apoE-VLDL uptake has not been established. We investigated if syndecan-1 (Syn-1), a transmembrane cell surface HSPG, is able to mediate the internalization of apoE-VLDL and examined the relationship between Syn-1 and LRP toward apoE-VLDL uptake. For this study, we used a human fibroblast cell line (GM00701) that expresses large amounts of LRP, but possesses no LDL receptor activity to eliminate its contributions toward apoE-VLDL uptake. Results Although LRP in these cells is fully active as established by substantial α2macroglobulin binding and internalization, uptake of apoE-VLDL is absent. Expression of human Syn-1 cDNA restored apoE-VLDL binding and uptake by these cells. Competition for this uptake with an LRP ligand-binding antagonist had little or no effect, whereas co-incubation with heparin abolished apoE-VLDL internalization. Depleting Syn-1 expressing cells of K+, to block clathrin-mediated endocytosis, showed no inhibition of Syn-1 internalization of apoE-VLDL. By contrast, treatment of cells with nystatin to inhibit lipid raft function, prevented the uptake of apoE-VLDL by Syn-1. Conclusion These data demonstrate that Syn-1 is able to mediate apoE-VLDL uptake in human fibroblasts with little or no contribution from LRP and that the endocytic path taken by Syn-1 is clathrin-independent and relies upon lipid raft function. These data are consistent with previous studies demonstrating Syn-1 association with lipid raft domains.
机译:背景技术富含三酰甘油的极低密度脂蛋白(VLDL)颗粒是循环中脂肪酸的主要载体,因此可作为周围组织的丰富能源。受体介导的这些颗粒的摄取取决于与载脂蛋白E(apoE-VLDL)的先前结合,并由某些细胞类型中的细胞表面硫酸乙酰肝素蛋白聚糖(HSPG)和低密度脂蛋白受体相关蛋白(LRP)引起在其他人。尽管已经充分研究了LRP在apoE-VLDL摄取中的作用,但尚未确定介导apoE-VLDL摄取的HSPG家族成员的身份。我们调查了跨膜细胞表面HSPG syndecan-1(Syn-1)是否能够介导apoE-VLDL的内在化,并研究了Syn-1和LRP之间对apoE-VLDL摄取的关系。在这项研究中,我们使用了表达大量LRP的人成纤维细胞系(GM00701),但它不具有LDL受体活性来消除其对apoE-VLDL摄取的影响。结果尽管这些细胞中的LRP通过充分的α2巨球蛋白结合和内在化建立了完全的活性,但apoE-VLDL的摄取却不存在。人Syn-1 cDNA的表达恢复了这些细胞对apoE-VLDL的结合和摄取。与LRP配体结合拮抗剂竞争这种摄取几乎没有影响,甚至没有,而与肝素共同孵育消除了apoE-VLDL内在化。消耗表达K +的Syn-1的细胞来阻断网格蛋白介导的内吞作用,并没有抑制apoE-VLDL的Syn-1内在化。相反,用制霉菌素处理细胞以抑制脂质筏功能,阻止了Syn-1对apoE-VLDL的吸收。结论这些数据表明,Syn-1能够介导人成纤维细胞中apoE-VLDL的吸收,而LRP几乎没有或没有贡献,并且Syn-1所采取的内吞途径与网格蛋白无关,并且依赖脂质筏功能。这些数据与先前的研究表明Syn-1与脂质筏域相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号